Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €24.98 EUR
Change Today +0.048 / 0.19%
Volume 87.9K
As of 3:35 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

celesio ag (CLS1) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/9/15 - €28.26
52 Week Low
08/24/15 - €24.42
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CELESIO AG (CLS1)

Related News

No related news articles were found.

celesio ag (CLS1) Related Businessweek News

No Related Businessweek News Found

celesio ag (CLS1) Details

Celesio AG provides logistics and services to the pharmaceutical and healthcare sectors worldwide. The company operates through two divisions, Consumer Solutions and Pharmacy Solutions. The Consumer Solutions division offers prescription and a range of over the counter pharmaceutical products. The Pharmacy Solutions division is involved in the wholesale of pharmaceutical products. It offers oncological products and other medicines for the treatment of complex diseases; and provides supplementary services for pharmacists, such as the organization and management of pharmacy cooperation programs. As of March 11, 2015, it served its customers through approximately 2,200 owned pharmacies and approximately 4,300 participants in its brand partnership schemes; and operated 133 wholesale branches that supplied pharmaceutical products to approximately 65,000 pharmacies and hospitals. The company was founded in 1835 and is headquartered in Stuttgart, Germany. Celesio AG is a subsidiary of McKesson Corporation.

25,279 Employees
Last Reported Date: 07/30/15
Founded in 1835

celesio ag (CLS1) Top Compensated Officers

Chairman of The Management Board, Chief Opera...
Total Annual Compensation: €336.0K
Chief Financial Officer and Member of the Man...
Total Annual Compensation: €184.0K
Group Legal Director, Group Compliance Office...
Total Annual Compensation: €149.0K
Compensation as of Fiscal Year 2015.

celesio ag (CLS1) Key Developments

Celesio AG Announces Earnings Results for the First Quarter of Fiscal Year 2016; Provides Earnings Guidance for Fiscal 2016

Celesio AG announced earnings results for the first quarter of fiscal year 2016. For the quarter, the company’s revenue was EUR 5,337.1 million. EBIT was EUR 119.9 million. Net profit was EUR 62.8 million. Earnings per share (basic) were EUR 0.31. The Management still expects adjusted EBIT for fiscal 2016 to be in line with the adjusted EBIT for the adjusted fiscal 2014 excluding the benefit in fiscal 2014 from the pension in Norway.

Celesio AG Reports Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016

Celesio AG reported earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported revenue of EUR 5,269.1 million against EUR 4,990.2 million a year ago. EBIT was EUR 62.2 million against EUR 91.0 million a year ago. Adjusted EBIT was EUR 78.6 million against EUR 98.0 million a year ago. Net profit was EUR 33.0 million against EUR 46.7 million a year ago. Adjusted net profit was EUR 47.7 million against EUR 53.7 million a year ago. Adjusted EBITDA was EUR 1.68 million against EUR 1.71 million a year ago. Net loss was EUR 222.3 million or EUR 0.22 per share basic against net profit of EUR 43.1 million or EUR 1.10 per share basic a year ago. For the year 2016, the company expects assumes that revenue from continued operations for fiscal 2016 will be flat compared to the adjusted fiscal 2014 as solid growth in Germany and the United Kingdom will be offset by continued weakness in France and the loss of a large hospital contract in Norway. The adjusted EBIT for continued operations for fiscal 2016 will be considerably below the level of the adjusted fiscal 2014 due to a non-recurring pension benefit in fiscal 2014 in Norway.

Celesio Put Its Businesses For Sale

Celesio AG (DB:CLS1) said that it would put its businesses in Brazil up for sale to allow it to focus on Europe. The assets include Panpharma and Oncoprod, Celesio said in a statement. "In selling its Brazilian operations, Celesio will increase its focus on European markets and customers," Celesio said.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLS1:GR €24.98 EUR +0.048

CLS1 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cardinal Health Inc $83.39 USD -0.30
McKesson Corp $200.80 USD +1.93
UDG Healthcare PLC 504.50 GBp +1.50
Walgreens Boots Alliance Inc $87.42 USD -0.43
View Industry Companies

Industry Analysis


Industry Average

Valuation CLS1 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 1.9x
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELESIO AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at